Evidence map›Paper›PMID 41350496›Full record

ArticleEJNMMI research2025

Prognostic value of molecular and radiologic characteristics on dedicated breast [

Melissa Lenaerts, Cornelis M de Mooij, Janneke B Houwers, Cristina Mitea, Marco Panosetti, Maaike de Boer, Kristien B M I Keymeulen, Felix M Mottaghy, Marc B I Lobbes, Patty J Nelemans and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Melissa LenaertsDepartment of Surgery, Maastricht University Medical Centre+, P.O. Box 5800, Maastricht, The Netherlands. melissa.lenaerts@maastrichtuniversity.nl.ORCID http://orcid.org/0000-0001-9687-4375
Cornelis M de MooijDepartment of Surgery, Maastricht University Medical Centre+, P.O. Box 5800, Maastricht, The Netherlands.
Janneke B HouwersDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Cristina MiteaGROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Marco PanosettiDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Maaike de BoerDepartment of Medical Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Kristien B M I KeymeulenDepartment of Surgery, Maastricht University Medical Centre+, P.O. Box 5800, Maastricht, The Netherlands.
Felix M MottaghyDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Marc B I LobbesDepartment of Medical Imaging, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands.
Patty J NelemansDepartment of Epidemiology, Maastricht University, Maastricht, The Netherlands.
Marjolein L SmidtDepartment of Surgery, Maastricht University Medical Centre+, P.O. Box 5800, Maastricht, The Netherlands.
Thiemo J A van NijnattenGROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to investigate the prognostic value of molecular and radiologic characteristics of the primary tumour and axillary lymph nodes (ALNs) on dedicated breast [

results41 patients with 42 breast tumours underwent dedicated breast [

conclusionsFor PET- and MRI-derived parameters, several post-NAC values were predictive of EFS, but no significant association between pre- and mid-NAC values and EFS was found.

Indexed as

Breast cancerFluorodeoxyglucose F18Magnetic resonance imagingNeoadjuvant therapyPositron emission tomographyPrognosis

Identifiers

PMID41350496
PMCPMC12796064

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.